AI assistant
Sending…
Vistin Pharma — Director's Dealing 2018
Nov 23, 2018
3782_dirs_2018-11-23_615e444d-abf3-47e0-809e-7f807bc7b306.html
Director's Dealing
Open in viewerOpens in your device viewer
Mandatory notification of trade
Mandatory notification of trade
Valborg Godal Vold, COO of Vistin Pharma ASA, and a primary insider, has on 18
September 2018 sold 50,000 shares in Vistin Pharma ASA at an average price of
NOK 10.58 per share. Following this sale Valborg Godal Vold holds 50,000 shares
in Vistin Pharma ASA.
More from Vistin Pharma
Notice of Dividend Amount
2026
May 22
AGM Information
2026
May 20
Report Publication Announcement
2026
May 20
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Proxy Solicitation & Information Statement
2026
Apr 28
Remuneration Information
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Annual Report
2026
Apr 28
Annual Report
2026
Apr 28
AGM Information
2026
Apr 28